These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 26781584)

  • 1. S100A4 and P53 in myocardial collagen fibers of hypertrophic cardiomyopathy : Expression and clinical significance.
    Qi X; Han J; Zhao P; Dong X; Gong S
    Herz; 2016 Sep; 41(6):530-3. PubMed ID: 26781584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Changes of left ventricular myocardial collagen fibers and osteopontin expression in hypertrophic cardiomyopathy].
    Tang DW; Lin GS; Huang JL; Liu C; Hao B; Yu YG; Kong XP; Quan L; Liao XB; Luo B
    Fa Yi Xue Za Zhi; 2012 Aug; 28(4):247-51. PubMed ID: 23033660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metastasis-associated protein, S100A4 mediates cardiac fibrosis potentially through the modulation of p53 in cardiac fibroblasts.
    Tamaki Y; Iwanaga Y; Niizuma S; Kawashima T; Kato T; Inuzuka Y; Horie T; Morooka H; Takase T; Akahashi Y; Kobuke K; Ono K; Shioi T; Sheikh SP; Ambartsumian N; Lukanidin E; Koshimizu TA; Miyazaki S; Kimura T
    J Mol Cell Cardiol; 2013 Apr; 57():72-81. PubMed ID: 23352991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S100A4 protects the myocardium against ischemic stress.
    Doroudgar S; Quijada P; Konstandin M; Ilves K; Broughton K; Khalafalla FG; Casillas A; Nguyen K; Gude N; Toko H; Ornelas L; Thuerauf DJ; Glembotski CC; Sussman MA; Völkers M
    J Mol Cell Cardiol; 2016 Nov; 100():54-63. PubMed ID: 27721024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of S100A4 Alleviates Cardiac Fibrosis via Wnt/β -Catenin Pathway in Mice.
    Qian L; Hong J; Zhang Y; Zhu M; Wang X; Zhang Y; Chu M; Yao J; Xu D
    Cell Physiol Biochem; 2018; 46(6):2551-2560. PubMed ID: 29758552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of the collagen volume fraction in hypertrophic cardiomyopathy.
    Arteaga E; de Araújo AQ; Bernstein M; Ramires FJ; Ianni BM; Fernandes F; Mady C
    Arq Bras Cardiol; 2009 Mar; 92(3):210-4, 216-20. PubMed ID: 19390710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating microRNAs as biomarkers for diffuse myocardial fibrosis in patients with hypertrophic cardiomyopathy.
    Fang L; Ellims AH; Moore XL; White DA; Taylor AJ; Chin-Dusting J; Dart AM
    J Transl Med; 2015 Sep; 13():314. PubMed ID: 26404540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aldosterone, through novel signaling proteins, is a fundamental molecular bridge between the genetic defect and the cardiac phenotype of hypertrophic cardiomyopathy.
    Tsybouleva N; Zhang L; Chen S; Patel R; Lutucuta S; Nemoto S; DeFreitas G; Entman M; Carabello BA; Roberts R; Marian AJ
    Circulation; 2004 Mar; 109(10):1284-91. PubMed ID: 14993121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lumican accumulates with fibrillar collagen in fibrosis in hypertrophic cardiomyopathy.
    Rixon C; Andreassen K; Shen X; Erusappan PM; Almaas VM; Palmero S; Dahl CP; Ueland T; Sjaastad I; Louch WE; Stokke MK; Tønnessen T; Christensen G; Lunde IG
    ESC Heart Fail; 2023 Apr; 10(2):858-871. PubMed ID: 36444917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comprehensive evaluation of myocardial fibrosis in hypertrophic cardiomyopathy with cardiac magnetic resonance imaging: linking genotype with fibrotic phenotype.
    Ellims AH; Iles LM; Ling LH; Chong B; Macciocca I; Slavin GS; Hare JL; Kaye DM; Marasco SF; McLean CA; James PA; du Sart D; Taylor AJ
    Eur Heart J Cardiovasc Imaging; 2014 Oct; 15(10):1108-16. PubMed ID: 24819852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antifibrotic effects of antioxidant N-acetylcysteine in a mouse model of human hypertrophic cardiomyopathy mutation.
    Marian AJ; Senthil V; Chen SN; Lombardi R
    J Am Coll Cardiol; 2006 Feb; 47(4):827-34. PubMed ID: 16487852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin II blockade reverses myocardial fibrosis in a transgenic mouse model of human hypertrophic cardiomyopathy.
    Lim DS; Lutucuta S; Bachireddy P; Youker K; Evans A; Entman M; Roberts R; Marian AJ
    Circulation; 2001 Feb; 103(6):789-91. PubMed ID: 11171784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrast-enhanced myocardial T1-weighted scout (Look-Locker) imaging for the detection of myocardial damages in hypertrophic cardiomyopathy.
    Amano Y; Takayama M; Kumita S
    J Magn Reson Imaging; 2009 Oct; 30(4):778-84. PubMed ID: 19787718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired left ventricular energy metabolism in patients with hypertrophic cardiomyopathy is related to the extension of fibrosis at delayed gadolinium-enhanced magnetic resonance imaging.
    Esposito A; De Cobelli F; Perseghin G; Pieroni M; Belloni E; Mellone R; Canu T; Gentinetta F; Scifo P; Chimenti C; Frustaci A; Luzi L; Maseri A; Maschio AD
    Heart; 2009 Mar; 95(3):228-33. PubMed ID: 18708417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of the -420C>G RETN polymorphism in myocardial fibrosis in patients with hypertrophic cardiomyopathy.
    Hernández-Romero D; Orenes-Piñero E; García-Honrubia A; Climent V; Romero-Aniorte AI; Martínez CM; García-Bautista M; Martínez M; Feliu E; González J; Cánovas S; Montero-Argudo JA; Valdés M; Marín F
    J Intern Med; 2015 Jul; 278(1):50-8. PubMed ID: 25476756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating the utility of circulating biomarkers of collagen synthesis in hypertrophic cardiomyopathy.
    Ellims AH; Taylor AJ; Mariani JA; Ling LH; Iles LM; Maeder MT; Kaye DM
    Circ Heart Fail; 2014 Mar; 7(2):271-8. PubMed ID: 24481111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional Stress-Induced Ischemia in Non-fibrotic Hypertrophied Myocardium in Young HCM Patients.
    Jablonowski R; Fernlund E; Aletras AH; Engblom H; Heiberg E; Liuba P; Arheden H; Carlsson M
    Pediatr Cardiol; 2015 Dec; 36(8):1662-9. PubMed ID: 26066352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T1 Mapping in Discrimination of Hypertrophic Phenotypes: Hypertensive Heart Disease and Hypertrophic Cardiomyopathy: Findings From the International T1 Multicenter Cardiovascular Magnetic Resonance Study.
    Hinojar R; Varma N; Child N; Goodman B; Jabbour A; Yu CY; Gebker R; Doltra A; Kelle S; Khan S; Rogers T; Arroyo Ucar E; Cummins C; Carr-White G; Nagel E; Puntmann VO
    Circ Cardiovasc Imaging; 2015 Dec; 8(12):. PubMed ID: 26659373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrocardiographic QRS Fragmentation as a Marker for Myocardial Fibrosis in Hypertrophic Cardiomyopathy.
    Konno T; Hayashi K; Fujino N; Oka R; Nomura A; Nagata Y; Hodatsu A; Sakata K; Furusho H; Takamura M; Nakamura H; Kawashiri MA; Yamagishi M
    J Cardiovasc Electrophysiol; 2015 Oct; 26(10):1081-7. PubMed ID: 26102305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial Fibrosis in Hypertrophic Cardiomyopathy: A Perspective from Fibroblasts.
    Schlittler M; Pramstaller PP; Rossini A; De Bortoli M
    Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.